SG11201404757WA - Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme - Google Patents

Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme

Info

Publication number
SG11201404757WA
SG11201404757WA SG11201404757WA SG11201404757WA SG11201404757WA SG 11201404757W A SG11201404757W A SG 11201404757WA SG 11201404757W A SG11201404757W A SG 11201404757WA SG 11201404757W A SG11201404757W A SG 11201404757WA SG 11201404757W A SG11201404757W A SG 11201404757WA
Authority
SG
Singapore
Prior art keywords
ubiquitin
activating enzyme
pyrazolopyrimidinyl
inhibitors
pyrazolopyrimidinyl inhibitors
Prior art date
Application number
SG11201404757WA
Other languages
English (en)
Inventor
Roushan Afroze
Indu T Bharathan
Jeffrey P Ciavarri
Paul E Fleming
Jeffrey L Gaulin
Mario Girard
Steven P Langston
Francois R Soucy
Tzu-Tshin Wong
Yingchun Ye
Original Assignee
Millennium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharm Inc filed Critical Millennium Pharm Inc
Publication of SG11201404757WA publication Critical patent/SG11201404757WA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
SG11201404757WA 2012-02-17 2013-02-14 Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme SG11201404757WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261600070P 2012-02-17 2012-02-17
PCT/US2013/026113 WO2013123169A1 (en) 2012-02-17 2013-02-14 Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme

Publications (1)

Publication Number Publication Date
SG11201404757WA true SG11201404757WA (en) 2014-09-26

Family

ID=48982730

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201606581RA SG10201606581RA (en) 2012-02-17 2013-02-14 Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme
SG11201404757WA SG11201404757WA (en) 2012-02-17 2013-02-14 Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10201606581RA SG10201606581RA (en) 2012-02-17 2013-02-14 Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme

Country Status (30)

Country Link
US (4) US9290500B2 (zh)
EP (3) EP2814791A4 (zh)
JP (1) JP6122877B2 (zh)
KR (1) KR20140123104A (zh)
CN (1) CN104136399B (zh)
AR (1) AR092797A1 (zh)
BR (1) BR112014020365B1 (zh)
CA (1) CA2864672C (zh)
CL (1) CL2014002181A1 (zh)
CO (1) CO7071135A2 (zh)
CR (1) CR20140380A (zh)
DO (1) DOP2014000187A (zh)
EA (1) EA035020B1 (zh)
EC (1) ECSP14019113A (zh)
ES (1) ES2739150T3 (zh)
GE (1) GEP201706687B (zh)
HK (1) HK1201817A1 (zh)
IL (1) IL234016A0 (zh)
MA (1) MA35932B1 (zh)
MX (1) MX352963B (zh)
NZ (1) NZ628969A (zh)
PE (1) PE20142244A1 (zh)
PH (1) PH12014501832A1 (zh)
SG (2) SG10201606581RA (zh)
TN (1) TN2014000351A1 (zh)
TW (1) TWI593688B (zh)
UA (1) UA116534C2 (zh)
UY (1) UY34629A (zh)
WO (1) WO2013123169A1 (zh)
ZA (1) ZA201406103B (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8008307B2 (en) 2006-08-08 2011-08-30 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of E1 activating enzymes
BR112014020365B1 (pt) 2012-02-17 2023-02-23 Takeda Pharmaceutical Company Limited Inibidores de pirazolopirimidinila de enzima de ativação de ubiquitina
CN104684559A (zh) 2012-08-03 2015-06-03 米伦纽姆医药公司 针对Uba6的吲哚取代的吡咯并嘧啶基抑制剂
US9695154B2 (en) 2013-07-02 2017-07-04 Millennium Pharmaceuticals, Inc. Heteroaryl inhibitors of sumo activating enzyme
UY36198A (es) 2014-07-01 2016-01-29 Millennium Pharm Inc Compuestos de heteroarilo útiles como inhibidores de enzima activadora de sumo
WO2016069392A1 (en) 2014-10-29 2016-05-06 Millennium Pharmaceuticals, Inc. Administration of ubiquitin-activating enzyme inhibitor and chemotherapeutic agents
WO2016069393A1 (en) 2014-10-29 2016-05-06 Millennium Pharmaceuticals, Inc. Administration of ubiquitin-activating enzyme inhibitor and radiation
MX2021004769A (es) 2018-10-30 2021-08-24 Kronos Bio Inc Compuestos, composiciones, y metodos para modular la actividad cdk9.
WO2023021498A1 (en) * 2021-08-16 2023-02-23 Moya Bio Ltd. Fused azole and furan based nucleoside analogs and uses thereof

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003073989A2 (en) 2002-02-28 2003-09-12 Biota, Inc. Nucleoside 5'-monophosphate mimics and their prodrugs
DE60313872T2 (de) 2002-09-04 2008-01-17 Schering Corp. Pyrazoloä1,5-aüpyrimidine als hemmstoffe cyclin-abhängiger kinasen
ES2285164T3 (es) 2002-09-04 2007-11-16 Schering Corporation Pirazolopirimidinas como inhibidores de quinasas dependientes de ciclina.
US7563798B2 (en) 2002-09-04 2009-07-21 Schering Corporation Substituted pyrazolo[1,5-a]pyrimidines as protein kinase inhibitors
US7196092B2 (en) 2002-09-04 2007-03-27 Schering Corporation N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors
EP1608652A1 (en) 2003-03-31 2005-12-28 Vernalis (Cambridge) Limited Pyrazolopyrimidine compounds and their use in medicine
JP2005008581A (ja) * 2003-06-20 2005-01-13 Kissei Pharmaceut Co Ltd 新規なピラゾロ[1,5−a]ピリミジン誘導体、それを含有する医薬組成物およびそれらの用途
WO2005037845A1 (en) 2003-10-17 2005-04-28 Rigel Pharmaceuticals, Inc. Benzothiazole and thiazole[5,5-b] pyridine compositions and their use as ubiquitin ligase inhibitors
EP1758873A1 (en) 2004-06-22 2007-03-07 Rigel Pharmaceuticals, Inc. Ubiquitin ligase inhibitors
JP5048520B2 (ja) 2005-02-04 2012-10-17 ミレニアム ファーマシューティカルズ, インコーポレイテッド E1活性化酵素の阻害剤
WO2007044426A2 (en) 2005-10-06 2007-04-19 Schering Corporation Pyrazolopyrimidines as protein kinase inhibitors
EP2402334B1 (en) 2006-02-02 2016-06-29 Millennium Pharmaceuticals, Inc. Inhibitors of E1 Activating Enzymes
EP1992008A1 (en) * 2006-02-28 2008-11-19 Sez Ag Device and method for liquid treating disc-like articles
MY157177A (en) 2006-08-08 2016-05-13 Millennium Pharm Inc Heteroaryl compounds useful as inhibitors of e1 activating enzymes
US8008307B2 (en) 2006-08-08 2011-08-30 Millennium Pharmaceuticals, Inc. Heteroaryl compounds useful as inhibitors of E1 activating enzymes
CN107021895A (zh) 2007-06-12 2017-08-08 尔察祯有限公司 抗菌剂
ES2758027T3 (es) * 2007-08-02 2020-05-04 Millennium Pharm Inc Intermedios para la síntesis de inhibidores de enzimas activadoras de actividad E1
US9216983B2 (en) 2007-12-21 2015-12-22 Board Of Regents, University Of Texas System Dihydroorotate dehydrogenase inhibitors with selective anti-malarial activity
WO2010086040A1 (en) 2009-01-29 2010-08-05 Biomarin Iga, Ltd. Pyrazolo-pyrimidines for treatment of duchenne muscular dystrophy
WO2010088518A2 (en) 2009-01-31 2010-08-05 Kalypsys, Inc. Heterocyclic modulators of gpr119 for treatment of disease
WO2010132110A1 (en) 2009-05-14 2010-11-18 Millennium Pharmaceuticals, Inc. Hydrochloride salt of ((1s,2s,4r)-4-{4-[(1s)-2,3-dihydro-1h-inden-1-ylamino]-7h-pyrrolo [2,3-d]pyrimidin-7-yl}-2-hydroxycyclopentyl)methyl sulfamate
JP5879273B2 (ja) 2010-03-01 2016-03-08 ジーティーエックス・インコーポレイテッド 癌を処置するための化合物
US20120077814A1 (en) 2010-09-10 2012-03-29 Zhong Wang Sulfonamide, sulfamate, and sulfamothioate derivatives
BR112014004239A2 (pt) 2011-08-24 2017-03-21 Millennium Pharm Inc inibidores de enzima ativadora de nedd8
BR112014020365B1 (pt) 2012-02-17 2023-02-23 Takeda Pharmaceutical Company Limited Inibidores de pirazolopirimidinila de enzima de ativação de ubiquitina
CN104684559A (zh) 2012-08-03 2015-06-03 米伦纽姆医药公司 针对Uba6的吲哚取代的吡咯并嘧啶基抑制剂
US9695154B2 (en) 2013-07-02 2017-07-04 Millennium Pharmaceuticals, Inc. Heteroaryl inhibitors of sumo activating enzyme
UY36198A (es) 2014-07-01 2016-01-29 Millennium Pharm Inc Compuestos de heteroarilo útiles como inhibidores de enzima activadora de sumo

Also Published As

Publication number Publication date
BR112014020365A2 (pt) 2020-12-22
TN2014000351A1 (en) 2015-12-21
EA201400831A1 (ru) 2014-12-30
CN104136399B (zh) 2018-08-07
TW201345909A (zh) 2013-11-16
MA35932B1 (fr) 2014-12-01
UY34629A (es) 2013-09-02
US20170369499A1 (en) 2017-12-28
PE20142244A1 (es) 2015-01-07
CN104136399A (zh) 2014-11-05
US20140088096A9 (en) 2014-03-27
EP2814791A4 (en) 2015-08-19
MX352963B (es) 2017-12-15
UA116534C2 (uk) 2018-04-10
EP3173413B1 (en) 2019-05-01
ZA201406103B (en) 2017-11-29
CA2864672C (en) 2018-01-09
EP3536692A1 (en) 2019-09-11
US20170217968A1 (en) 2017-08-03
EP2814791A1 (en) 2014-12-24
MX2014009944A (es) 2014-11-10
US10202389B2 (en) 2019-02-12
KR20140123104A (ko) 2014-10-21
ES2739150T3 (es) 2020-01-29
EP3536692B1 (en) 2021-04-07
JP6122877B2 (ja) 2017-04-26
GEP201706687B (en) 2017-06-26
CA2864672A1 (en) 2013-08-22
CR20140380A (es) 2014-10-28
CL2014002181A1 (es) 2014-12-12
SG10201606581RA (en) 2016-09-29
BR112014020365B1 (pt) 2023-02-23
TWI593688B (zh) 2017-08-01
IL234016A0 (en) 2014-09-30
US20130217682A1 (en) 2013-08-22
NZ628969A (en) 2017-03-31
EP3173413A1 (en) 2017-05-31
CO7071135A2 (es) 2014-09-30
US9290500B2 (en) 2016-03-22
WO2013123169A1 (en) 2013-08-22
US9796725B2 (en) 2017-10-24
ECSP14019113A (es) 2015-09-30
US20160244455A1 (en) 2016-08-25
PH12014501832A1 (en) 2014-11-17
HK1201817A1 (zh) 2015-09-11
EA035020B1 (ru) 2020-04-17
JP2015508775A (ja) 2015-03-23
DOP2014000187A (es) 2014-10-15
US9663525B2 (en) 2017-05-30
AR092797A1 (es) 2015-05-06

Similar Documents

Publication Publication Date Title
HK1207078A1 (zh) 酶的抑制
HK1201519A1 (zh) 磷酸二酯酶第 型的抑制劑
HK1210140A1 (zh) 作為 複合物的抑制劑的稠合嘧啶
HK1206736A1 (zh) 抑制劑及其製備和使用方法
EP2903613A4 (en) INHIBITORS OF IRAQ4 ACTIVITY
EP2903617A4 (en) INHIBITORS OF IRAQ4 ACTIVITY
AP4029A (en) Inhibitors of beta-secretase
LT2855480T (lt) Pteridinai kaip fgfr inhibitoriai
HK1201817A1 (zh) 泛素活化酶的吡唑並嘧啶基抑製劑
HK1199252A1 (zh) -活化酶的抑制劑
HK1211024A1 (zh) 的抑制劑
IL236963A0 (en) beta-secretase inhibitors
LT2931710T (lt) Piridazinonai kaip daao fermento slopikliai
HK1201066A1 (zh) 端錨聚合酶的吡喃並吡啶酮抑制劑
PL2888228T3 (pl) Inhibitory oddziaływania CD40-TRAF6
EP2714667A4 (en) AMINOOXAZOLE INHIBITORS OF KINASES DEPENDENT OF CYCLIN
AP2014007697A0 (en) Quinoline derivatives as PDE1OA enzyme inhibitors
GB201312311D0 (en) Uses of enzyme inhibitors
GB201223308D0 (en) Enzyme inhibitors
AU2012905067A0 (en) IMPROVED INHIBITORS OF Grb7